Belgian healthcare providers demand transparency on foreign degree recognition
Published 2 d ago4 sourcesEvidence: Reported
Belgian mutuality Solidaris and union Setca condemn GSK's restructuring as 'indecent', citing 2.4 billion euros net profit in 2025 for GSK Biologicals, major public aid, and 200 million in drug reimbursements. They argue high cancer drug prices drive the sector's demand for 'delusional' profitability, leading to job cuts. The dispute highlights tensions between corporate profit motives and public healthcare costs in Belgium.
Published 2 d ago4 sourcesEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 17 h ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 h ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported